治疗性结肠炎和克罗恩病:目标应该是内镜,组织学还是两者兼而有之?
Fernando Magro1,2,3,4, Maria Manuela Estevinho1,5, André Valois4
1Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Porto, Portugal.
粘膜愈合是炎症性肠病 (IBD) 长期结果的关键. 组织学缓解,特别是在性结肠炎中,提供了最佳的预后,并应指导治疗,对于克罗恩氏病需要进一步的研究.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 粘膜愈合是炎症性肠病 (IBD) 的首要长期目标.
- 评估内镜和组织学结果对于评估治疗疗效至关重要.
- 正在开发新的药理干预措施,以实现IBD更深层次的缓解.
研究的目的:
- 审查新疗法促进IBD内镜和组织学愈合的能力.
- 讨论内镜和组织学结果的预后意义.
- 识别当前评估方法中的差距,并建议未来的研究方向.
主要方法:
- 分析自2020年以来发表的随机对照试验.
- 专注于影响IBD内镜和组织学缓解的药理干预措施.
- 对性结肠炎和克罗恩病的当前评分系统的审查.
主要成果:
- 组织学缓解显示出最佳的长期预后,支持其作为性结肠炎治疗指南的使用.
- 标准化组织学评分在性结肠炎试验中很常见 (例如,吉博斯评分,南希指数),但不是克罗恩病 (CD).
- 内镜评分通常用于性结肠炎,但在CD临床研究中受到限制.
结论:
- 组织学缓解是IBD长期结果的强有力的预测因素,特别是性结肠炎.
- 需要进一步的研究来验证和实施CD的组织学评分.
- 整合人工智能和定义缓解期患者的监测协议是未来的优先事项.
更多相关视频
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
07:05Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
